Log In
BCIQ
Print this Print this
 

2862277

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTumor necrosis factor receptor-1 (TNFR1) domain antibody
Molecular Target Tumor necrosis factor (TNF) receptor 1 (TNFRSF1A) (TNFR1) (CD120a)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today